• Neurotransmitter metabolites and clinical manifestations of neuropsychiatric developmental disorders in children under conditions of chronic social stress
en To content Full text of article

Neurotransmitter metabolites and clinical manifestations of neuropsychiatric developmental disorders in children under conditions of chronic social stress

Modern Pediatrics. Ukraine. (2026).2(154): 105-110. doi: 10.15574/SP.2026.2(154).105110
Grechanin Ya. R.¹, Kupriychuk Y. N
¹Kharkiv National Medical University, Ukraine
²MNPE of Kharkiv Regional Council "Interregional Specialized Medical and Genetic Center for Rare (Orphan) Diseases", Ukraine

For citation: Grechanin YaR, Kupriychuk YN. (2026). Neurotransmitter metabolites and clinical manifestations of neuropsychiatric developmental disorders in children under conditions of chronic social stress. Modern Pediatrics. Ukraine. 2(154): 105-110. doi: 10.15574/SP.2026.2(154).105110.
Article received: Dec 07, 2025. Accepted for publication: Mar 16, 2026.

Chronic social stress in childhood is associated with disruption of the body's adaptive mechanisms and the development of neuropsychiatric developmental disorders. Analysis of neurotransmitter metabolites enables assessment of the functional state of stress-response systems.
Aim – to investigate associations between neurotransmitter metabolite levels and clinical manifestations of neuropsychiatric developmental disorders in children under conditions of chronic social stress.
Materials and methods. The study included 186 children aged 1-8 years. The main group consisted of 80 children who permanently lived in the city of Kharkiv and the Kharkiv region and were exposed to a high intensity of military influence and chronic social stress. The comparison group included 65 children from regions with lower intensity of military influence and a relatively stable social and everyday environment. The control group consisted of 41 children examined in the pre-war period. The levels of vanillylmandelic acid (VMA), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in the morning urine samples were determined by gas chromatography-mass spectrometry.
Results. Children exposed to chronic social stress demonstrated a statistically significant increase in the frequency of altered VMA, HVA, and 5-HIAA levels compared to the comparison and control groups. These alterations were associated with speech development delay, emotional lability, sleep disturbances, behavioral abnormalities, and manifestations of autonomic dysfunction. The most pronounced changes were observed in the older age subgroup, correlating with longer duration of psychoemotional stress exposure.
Conclusions. Alterations in neurotransmitter metabolites in children under chronic social stress reflect impaired neurometabolic adaptation and may serve as potential laboratory biomarkers of neuropsychiatric developmental disorders. Urinary determination of VMA, HVA, and 5-HIAA represents a promising non-invasive approach for evaluating the functional status of stress-response systems in the pediatric population.
The study was conducted in accordance with the principles of the Declaration of Helsinki. The research protocol was approved by the Local Ethics Committee of the institution specified in the study. Informed parental consent was obtained for participation in the study.
The authors declare no conflict of interest.
Keywords: chronic social stress; children; neuropsychiatric developmental disorders; neurotransmitter metabolites; vanillylmandelic acid; homovanillic acid, 5-hydroxyindoleacetic acid.

REFERENCES

1. Abudayya A, Bruaset GTF, Nyhus HB et al. (2023). Consequences of war-related traumatic stress among Palestinian young people in the Gaza Strip: a scoping review. Mental Health & Prevention. 32: 1-12. https://doi.org/10.1016/j.mhp.2023.200295

2. Agorastos A, Pervanidou P, Chrousos GP, Baker DG. (2019). Developmental trajectories of early life stress and trauma: A narrative review on neurobiological aspects beyond stress system dysregulation. Front Psychiatry. 10: 118. eCollection 2019. https://doi.org/10.3389/fpsyt.2019.00118; PMid:30914979 PMCid:PMC6421311

3. Condon EM. (2018). Chronic stress in children and adolescents: A review of biomarkers for use in pediatric research. Biol Res Nurs. 20(5): 473-496. https://doi.org/10.1177/1099800418779214; PMid:29865855 PMCid:PMC6346321

4. Davis SL, Latimer M, Rice M. (2023). Biomarkers of stress and inflammation in children. Biol Res Nurs. 25(4): 559-570. https://doi.org/10.1177/10998004231168805; PMid:37010976 PMCid:PMC10626617

5. Kuhlman KR, Geiss EG, Vargas I, Lopez-Duran N. (2018). HPA-axis activation as a key moderator of childhood trauma exposure and adolescent mental health. J Abnorm Child Psychol. 46(1): 149-157. https://doi.org/10.1007/s10802-017-0282-9; PMid:28215023 PMCid:PMC10588887

6. Li D, Yu S, Long Y et al. (2022). Tryptophan metabolism: mechanism-oriented therapy for neurological and psychiatric disorders. Front Immunol. 13: 985378. https://doi.org/10.3389/fimmu.2022.985378; PMid:36159806 PMCid:PMC9496178

7. Makris G, Eleftheriades A, Pervanidou P. (2023). Early life stress, hormones, and neurodevelopmental disorders. Horm Res Paediatr. 96(1): 17-24. https://doi.org/10.1159/000523942; PMid:35259742

8. Mellon SH., Gautam A, Hammamieh R, Jett M, Wolkowitz OM. (2018). Metabolism, metabolomics, and inflammation in posttraumatic stress disorder. Biol Psychiatry. 83(10): 866-875. https://doi.org/10.1016/j.biopsych.2018.02.007; PMid:29628193

9. Menke A. (2023). The HPA axis as target for depression. Curr Neuropharmacol. 22(5): 904-915. https://doi.org/10.2174/1570159X21666230811141557; PMid:37581323 PMCid:PMC10845091

10. Nela A. (2024). Psychological effects of armed conflicts on children. The Global Psychotherapist. 4(1): 132-138. https://doi.org/10.52982/lkj227

11. Niu L, Gao Q, Xie M et al. (2025). Association of childhood adversity with HPA axis activity in children and adolescents: a systematic review and meta-analysis. Neurosci Biobehav Rev. 172: 106124. https://doi.org/10.1016/j.neubiorev.2025.106124; PMid:40157436

12. Oh DL, Jerman P, Silvério Marques S et al. (2018). Systematic review of pediatric health outcomes associated with childhood adversity. BMC Pediatr. 18(1): 83. https://doi.org/10.1186/s12887-018-1037-7; PMid:29475430 PMCid:PMC5824569

13. Pan X, Kaminga AC, Wen SW, Liu A. (2018). Catecholamines in post-traumatic stress disorder: a systematic review and meta-analysis. Front Mol Neurosci. 11: 450. https://doi.org/10.3389/fnmol.2018.00450; PMid:30564100 PMCid:PMC6288600

14. Paraniak-Gieszczyk B, Ogłodek EA. (2025). Neurobiological and existential profiles in posttraumatic stress disorder: the role of serotonin, cortisol, noradrenaline, and IL-12 across chronicity and age. Int J Mol Sci. 26(19): 9636. https://doi.org/10.3390/ijms26199636; PMid:41096899 PMCid:PMC12524811

15. Rozenblat S, Nitzan T, Matz Vaisman T et al. (2024). Autistic children and their parents in the context of war: preliminary findings. Stress Health. 40(5): e3442. https://doi.org/10.1002/smi.3442; PMid:38970246

16. Samara M, Hammuda S, Vostanis P, El-Khodary B, Al-Dewik N. (2020). Children's prolonged exposure to the toxic stress of war trauma in the Middle East. BMJ. 371: m3155. https://doi.org/10.1136/bmj.m3155; PMid:33214133 PMCid:PMC7673908

17. Samsonov A, Urlacher SS. (2025). Oxidative stress in children and adolescents: insights into human biology. Am J Hum Biol. 37(1): e24200. https://doi.org/10.1002/ajhb.24200; PMid:39815753 PMCid:PMC11736247

18. Sheppard M, Rasgado-Toledo J, Duncan N et al. (2024). Noradrenergic alterations associated with early life stress. Neurosci Biobehav Rev. 164: 105832. https://doi.org/10.1016/j.neubiorev.2024.105832; PMid:39084582

19. Sparrow SS, Cicchetti DV, Saulnier CA. (2016). Vineland Adaptive Behavior Scales: Comprehensive Parent/Caregiver Form Report. San Antonio, TX: Pearson.

20. Stein AD, Adair LS, Donati G et al. (2023). Early-life stature, preschool cognitive development, schooling attainment, and cognitive functioning in adulthood: a prospective study in four birth cohorts. Lancet Glob Health. 11(1): e95-e104. https://doi.org/10.1016/S2214-109X(22)00448-X; PMid:36521958 PMCid:PMC9764453

21. Sugama S, Kakinuma Y. (2021). Noradrenaline as a key neurotransmitter in modulating microglial activation in stress response. Neurochem Int. 143: 104943. https://doi.org/10.1016/j.neuint.2020.104943; PMid:33340593